SecSonar.com

Edwards Lifesciences Corporation (EW)

Edwards Lifesciences Corporation at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Edwards Lifesciences Corporation (EW) is a Medical - Devices company based in US with a market capitalization of $49.6B. Revenue grew 11.6% year-over-year and the company generated $1.3B in free cash flow. This page tracks EW's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 15.8K employees · IPO Mar 27, 2000

Valuation

Valuation & price

$81.38 · as of May 17, 2026 · -13.6% vs 52w high

44.4

P/E ratio

Latest-FY diluted EPS

4.80

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$94.22$83.44$72.65Jul 25Dec 25Jul 26Jul 7, 25$76.69Jul 9, 25$77.19Jul 11, 25$78.05Jul 15, 25$76.81Jul 17, 25$76.18Jul 21, 25$76.56Jul 23, 25$76.91Jul 25, 25$80.00Jul 29, 25$80.47Jul 31, 25$79.31Aug 4, 25$80.09Aug 6, 25$78.61Aug 11, 25$78.16Aug 13, 25$77.68Aug 15, 25$78.26Aug 19, 25$78.93Aug 21, 25$81.16Aug 25, 25$80.86Aug 27, 25$80.90Aug 29, 25$81.34Sep 3, 25$81.22Sep 5, 25$80.94Sep 9, 25$79.80Sep 11, 25$78.01Sep 16, 25$75.09Sep 18, 25$74.55Sep 22, 25$73.75Sep 24, 25$74.66Sep 26, 25$76.25Sep 30, 25$77.77Oct 2, 25$76.65Oct 6, 25$76.56Oct 8, 25$75.74Oct 10, 25$73.94Oct 14, 25$73.36Oct 16, 25$72.65Oct 21, 25$76.02Oct 23, 25$76.53Oct 27, 25$80.82Oct 29, 25$82.69Oct 31, 25$82.45Nov 4, 25$84.15Nov 6, 25$82.44Nov 10, 25$84.08Nov 12, 25$85.58Nov 14, 25$86.30Nov 18, 25$84.04Nov 20, 25$84.09Nov 25, 25$86.82Nov 28, 25$86.67Dec 2, 25$84.71Dec 4, 25$85.78Dec 8, 25$84.32Dec 10, 25$83.92Dec 12, 25$83.08Dec 16, 25$85.32Dec 18, 25$84.80Dec 22, 25$86.53Dec 24, 25$86.29Dec 29, 25$86.94Jan 2, 26$85.33Jan 6, 26$85.85Jan 8, 26$84.58Jan 12, 26$83.01Jan 14, 26$83.10Jan 16, 26$84.35Jan 21, 26$85.14Jan 23, 26$83.66Jan 27, 26$83.60Jan 29, 26$81.49Feb 2, 26$82.65Feb 4, 26$79.77Feb 9, 26$76.80Feb 11, 26$79.33Feb 13, 26$75.87Feb 18, 26$78.98Feb 20, 26$79.78Feb 24, 26$82.40Feb 26, 26$85.90Mar 2, 26$87.18Mar 4, 26$85.22Mar 6, 26$81.64Mar 10, 26$85.78Mar 12, 26$84.62Mar 17, 26$84.27Mar 19, 26$82.46Mar 23, 26$82.02Mar 25, 26$82.67Mar 27, 26$79.34Mar 31, 26$80.08Apr 2, 26$81.05Apr 7, 26$80.84Apr 9, 26$79.15Apr 13, 26$78.12Apr 15, 26$78.20Apr 17, 26$80.99Apr 22, 26$81.53Apr 24, 26$84.15Apr 28, 26$82.28Apr 30, 26$83.50May 4, 26$83.33May 6, 26$83.20May 8, 26$79.96May 12, 26$79.73May 14, 26$81.34May 18, 26$82.39May 20, 26$82.97May 22, 26$85.78May 28, 26$85.96Jun 1, 26$88.16Jun 3, 26$86.00Jun 5, 26$85.96Jun 9, 26$87.54Jun 11, 26$85.76Jun 15, 26$86.28Jun 17, 26$86.68Jun 22, 26$85.88Jun 24, 26$89.66Jun 26, 26$90.78Jul 2, 26$94.22
$72.6552-week range$94.22
Loading valuation history…

Fundamentals

Key fundamentals

$49.6B

Market cap

11.6%

Revenue growth (YoY)

78.1%

Gross margin

$1.3B

Free cash flow (USD)

-$3.5B

Net debt

Net cash position

-2.2%

Share dilution

3/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$3.0BFY 2017$3.4BFY 2018$3.7BFY 2019$4.3BFY 2020$4.4BFY 2021$5.2BFY 2022$5.4BFY 2023$5.0BFY 2024$5.4BFY 2025$6.1B
$3B$6.1B

Free cash flow by year

2016 → 2025

FY 2016$487.0MFY 2017$825.2MFY 2018$685.1MFY 2019$901.0MFY 2020$647.0MFY 2021$1.4BFY 2022$953.4MFY 2023$629.5MFY 2024$289.9MFY 2025$1.3B
$487M$1.3B

Gross margin by year

2021 → 2025

FY 202176.6%FY 202278.3%FY 202379.3%FY 202479.5%FY 202578.1%
76.6%78.1%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

1

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 6, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • Insider sellInsider Sell $57K · 10b5-1 PlanLippis Daniel J. · CVP, TAVR · $56.6KJun 30, 2026Filing
  • 8-K eventStock Incentive Program ApprovedMay 8, 2026Filing
  • Quarterly report10-Q FiledMay 6, 2026Filing
  • 8-K eventCFO AppointmentMay 4, 2026Filing
  • 8-K eventEarnings ReleaseApr 23, 2026Filing

Questions

Frequently asked questions

What is Edwards Lifesciences Corporation's market cap?

Edwards Lifesciences Corporation (EW) has a market capitalization of $49.6B.

What is EW's P/E ratio?

EW trades at a price-to-earnings ratio of 44.4, based on its latest fiscal-year diluted earnings per share and the most recent cached price.

What is EW's price-to-book (P/B) ratio?

EW trades at 4.80 times book value per share.

Are insiders buying EW stock?

SEC Form 4 filings show no open-market insider buys at Edwards Lifesciences Corporation in the last 90 days (1 sell).

Same arena

Related companies in Medical - Devices

DXCM

DexCom, Inc.

$28.4B

RMD

ResMed Inc.

$28.3B

BSX

Boston Scientific Corporation

$71.7B

PHG

Koninklijke Philips N.V.

$25.3B

STE

STERIS plc

$20.9B

ZBH

Zimmer Biomet Holdings, Inc.

$16B

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.